|
#1
|
||||
|
||||
|
An experimental vaccine prevented HIV infections for the first time, a breakthrough that has eluded scientists for a quarter century. A U.S.-funded study involving more than 16,000 volunteers in Thailand found that a combination of ALVAC, made by Paris- based Sanofi-Aventis SA, and AIDSVAX, from VaxGen Inc., of South San Francisco, cut infections by 31.2 percent in the people who received it compared with those on a placebo, scientists said today in Bangkok. Neither vaccine had stopped the virus that causes AIDS when tested separately in previous studies. The finding represents a revival in a campaign that appeared to stall just two years ago when use of Merck & Co.’s experimental Ad5 vaccine boosted some people’s chances of infection in a study. The latest result will transform future research, said Mitchell Warren, director of the New York-based AIDS Vaccine Advocacy Coalition. Read More: http://www.pinkbananaworld.com/conte....cfm?id=279328 |
![]() |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
|
|
All times are GMT. The time now is 12:59 AM.








